Aventis Pharma S.A. v. Sandoz, Inc.
333 F. App'x 521
CourtCourt of Appeals for the Federal Circuit
DecidedMay 20, 2009
DocketNos. 2008-1560, 2008-1563, 2008-1591
StatusPublished
This text of 333 F. App'x 521 (Aventis Pharma S.A. v. Sandoz, Inc.) is published on Counsel Stack Legal Research, covering Court of Appeals for the Federal Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.
Bluebook
Aventis Pharma S.A. v. Sandoz, Inc., 333 F. App'x 521 (Fed. Cir. 2009).
Opinion
ORDER
Aventis Pharma S.A., et al. move unopposed to dismiss these appeals. Sandoz, Inc. moves to renew its motion for attorney fees and costs.
IT IS ORDERED THAT:
(1) The motion to dismiss is granted.
(2) The motion for fees and costs is denied.
(3) Each party shall bear its own costs.
Free access — add to your briefcase to read the full text and ask questions with AI
Cite This Page — Counsel Stack
Bluebook (online)
333 F. App'x 521, Counsel Stack Legal Research, https://law.counselstack.com/opinion/aventis-pharma-sa-v-sandoz-inc-cafc-2009.